Improved VO 2 max following anti-IL-5 therapy in severe eosinophilic CRSwNP: exploratory associations with cardiac inflammatory biomarkers

European Clinical Respiratory Journal · Available online 9 Jul 2026 · In press · DOI 10.1080/20018525.2026.2700828

Free full text

Authors (5)

Jens Tidemandsen, Kasper Rossing, Anne Sophie Homøe, Morten Hostrup, Vibeke Backer

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2026

Citation

Tidemandsen, J., Rossing, K., Homøe, A., et al. (2026). Improved VO 2 max following anti-IL-5 therapy in severe eosinophilic CRSwNP: exploratory associations with cardiac inflammatory biomarkers. European Clinical Respiratory Journal. https://doi.org/10.1080/20018525.2026.2700828

Related articles